Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
251
-
Total 13F shares, excl. options
-
69,039,641
-
Shares change
-
+1,895,958
-
Total reported value, excl. options
-
$5,817,841,762
-
Value change
-
+$164,149,700
-
Put/Call ratio
-
97.18%
-
Number of buys
-
123
-
Number of sells
-
-104
-
Price
-
$84.27
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q4 2019
312 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q4 2019.
NovoCure Ltd - Common Stock (NVCR) has 251 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69,039,641 shares
of 111,111,111 outstanding shares and own 62.14% of the company stock.
Largest 10 shareholders include FMR LLC (12,179,429 shares), BAILLIE GIFFORD & CO (8,008,982 shares), VANGUARD GROUP INC (7,253,370 shares), BlackRock Inc. (5,733,317 shares), Capital World Investors (5,035,320 shares), RENAISSANCE TECHNOLOGIES LLC (2,241,995 shares), STATE STREET CORP (1,668,610 shares), Capital International Investors (1,380,675 shares), MORGAN STANLEY (1,352,895 shares), and Darsana Capital Partners LP (1,350,000 shares).
This table shows the top 251 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.